Order results by:
| Issue | Title | |
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... additional therapy with micellar curcumin for 6 months (IFN-C group). Clinical (relapses, MRI activity, EDSS ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... cases. Curcumin, a natural polyphenol, has immunoregulatory properties and a favorable safety profile ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... DMTs and reduce the likelihood of switching to switch to second line DMTs. Curcumin is one ..." | ||
| Vol 17, No 3 (2025) | Interrelation and mutual influence of mental health and reproductive function in women with infertility undergoing in vitro fertilization therapy | Abstract similar documents |
| A. O. Nikolaevskaya, N. A. Tyuvina, V. V. Balabanova, M. A. Vasilenko | ||
| "... . In vitro fertilization (IVF), while providing a method to overcome infertility, also entails a few ..." | ||
| Vol 12, No 5 (2020) | Assisted reproductive technologies: psychoneurological, moral-ethical, and socio-cultural aspects | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, A. O. Nikolaevskaya | ||
| "... , such as in vitro fertilization (IVF) and surrogacy. It shows the specificity of the impact of an IVF procedure ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... -year risk of reaching 6.5 Expanded Disability Status Scale (EDSS) scores. Patients and methods ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... Expanded Disability Status Scale (EDSS) score was 4.0; the most severe course of the disease was observed ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... functional system (PFS) impairment according to EDSS, patients were divided into 2 groups; group 1 — 17 ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... Status Scale (EDSS) and the Multiple Sclerosis Severity Score (MSSS). All patients were examined ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... was evaluated using the expanded disability status scale (EDSS); pedographic examination was made applying ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... ’s neurological deficit progressed to 9.5 points on the Expanded Disability Status Scale (EDSS). After ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... Hospital One. The Expanded Disability Status Scale (EDSS) was used to evaluate the severity of the disease ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... age 32.9 years, mean EDSS severity 3.8 points) with MS underwent outpatient continuous active art ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... , cervical and thoracic spine, and chest X-ray, Expanded Disability Status Scale (EDSS) scoring, clinical ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... in the EDSS range up to 5.5 points – the step width, the value of which is greater in patients with ataxia ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... scale (VAS) for pain, PASAT test, EDSS. We performed an MRI scan, and identified significant stressful ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... .47 years), mean Expanded Disability Status Scale (EDSS) score – 2.91±1.67. 86% of patients had relapsing ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Scale (EDSS), complete blood count, monitoring of blood lymphocytes level and biochemical blood testing ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
| A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
| "... and cerebellar ataxia. Students also had a faster MS progression (0.4 [0.2; 0.6] EDSS scores per year, p=0 ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... risk of a>0.75 point disability increase in the Expanded Disability Status Scale (EDSS) score ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... imaging (MRI) (at least 1.5 T) and electroencephalography (EEG), EDSS health assessment, antiepileptic ..." | ||
| Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
| A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
| "... condition was assessed using the Expanded Disability Status Scale (EDSS). Results. MS was diagnosed in 99 ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... 15 to 60 years (mean age 39.7±10.91 years). Disability according to the EDSS scale was 2.51±1 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... of patients who participated in TeleRBT, the level of disability on the EDSS scale did not change; walking ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... year of treatment and by 97.4% after the second year of treatment. The mean EDSS score was 3.2±2 ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... and 5 men; age – 41.6±7.7 years; EDSS – 4.0 [3.5; 5.0] points, duration of MS – 8.0 [3.0; 21.0] years ..." | ||
| Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
| "... and severity of the pain syndrome: Expanded Disability Status Scale (EDSS), Diagnostic Neuropathic Pain ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... by the average annualized relapse rate, the median changes of the Expanded Disability Status Scale (EDSS ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... of exacerbations and an increase in Expanded Disability Status Scale (EDSS) scores prior to being prescribed ..." | ||
| Vol 7, No 2 (2015) | Postoperative encephalopathy: Pathophysiological and morphological bases of its prevention under general anesthesia | Abstract similar documents |
| A. M. Ovezov, A. V. Knyazev, M. V. Panteleeva, M. A. Lobov, M. N. Borisova, A. V. Lugovoy | ||
| "... In vitro and in vivo studies have provided sufficient evidence of the neurotoxicity of general ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... disorders revealed significant differences between the groups in terms of such parameters as fatigue (p=0.003 ..." | ||
| Vol 4, No 4 (2012) | Analysis of the contribution of -5t/c polymorphism in the GP1BA gene to the development of ischemic stroke in young patients | Abstract similar documents |
| V I Skvortsova, E A Koltsova, Ekaterina Igorevna Kimelfeld, S A Limborskaya, P A Slominsky, T V Tupitsyna | ||
| "... individuals; p = 0.03; OR 2.7; CI 1.14; 6.47). This association was not found in the women. Analysis ..." | ||
| Vol 13, No 5 (2021) | Impact of mental disorders on COVID-19 outcomes | Abstract similar documents |
| N. N. Petrova, V. E. Pashkovskiy, M. S. Sivashova, A. N. Gvozdetsky, G. A. Prokopovich | ||
| "... hospitalizations (HR 4.55; 95% CI 1.66–12.48; p=0.003). The severity of coronavirus infection makes the greatest ..." | ||
| Vol 13, No 4 (2021) | Rehabilitation of patients after lumbar microdiscectomy | Abstract similar documents |
| V. S. Prokopovich, V. A. Parfenov | ||
| "... in the kinesitherapy group and up to 8 points in the group without kinesitherapy (p=0.003). Reoperations were required ..." | ||
| Vol 10, No 4 (2018) | Environmental factors and a risk for multiple sclerosis in the Altai Territory | Abstract similar documents |
| I. P. Saldan, I. V. Smagina, S. A. Elchaninova | ||
| "... and towns than in villages (p=0.003), in areas with heavy metal (lead and molybdenum) ore deposits, chemical ..." | ||
| Vol 13, No 2 (2021) | Pain reliever combinations in treatment of patients with acute musculoskeletal back pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, D. I. Lebedeva, I. V. Choi | ||
| "... was noted in both groups; pain reduction by 50% or more from the initial level prevailed in 1st group (p=0.03 ..." | ||
| Vol 12, No 1 (2020) | Gender characteristics of therapy for genetic generalized epilepsy in adults | Abstract similar documents |
| I. V. Volkov, G. S. Karpovich, A. V. Kalina, O. K. Volkova | ||
| "... slightly less often. In Group 2, females used polytherapy more frequently than males (p=0.03 ..." | ||
| Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
| "... association of the A allele of MT-ND5 (m. 13708G>A) with MS (p=0.03) (OR 1.89; 95% CI 1.11–3.32). Sex ..." | ||
| Vol 9, No 4 (2017) | In-hospital stroke in patients after cardiac surgery or invasive interventions | Abstract similar documents |
| P. A. Filimonova, L. I. Volkova, A. M. Alasheev, A. V. Mikhaylov, E. A. Grichuk | ||
| "... grafting is about 2%; that after valve surgery and percutaneous cardiac intervention is 1 to 10% and 0.03 ..." | ||
| Vol 9, No 3 (2017) | Neuroprotective properties of lithium salts during glutamate-induced stress | Abstract similar documents |
| A. V. Pronin, O. A. Gromova, I. Yu. Torshin, E. V. Stelmashuk, O. P. Aleksandrova, E. E. Genrikhs, L. G. Khaspekov | ||
| "... increased the survival rate of CGNs by an average of 30% (p < 0.003). The active neuroprotective principles ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... was found in 49% of patients. It occurred more frequently (χ2=9.546; p=0.003) in patients taking amantadine ..." | ||
| Vol 16, No 3 (2024) | Optic neuritis in various demyelinating diseases | Abstract PDF (Eng) similar documents |
| A. K. Kalashnikova, D. D. Eliseeva, N. A. Andreeva, N. V. Zhorzholadze, I. A. Ronzina, R. Ts. Bembeeva, N. N. Venediktova, M. R. Kalganova, N. L. Sheremet | ||
| "... -ON with a single episode was comparable to that of MS/iDON (p=0.2), but recovery was less pronounced (p=0.03 ..." | ||
| Vol 16, No 3 (2024) | The influence of the mental state of women with infertility on their reproductive status | Abstract PDF (Eng) similar documents |
| A. O. Nikolaevskaya, N. A. Tyuvina, V. V. Balabanova | ||
| "... to the in vitro fertilization procedure. They have a rational approach to pregnancy planning, are characterized ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... .04), the BDI (p=0.003), and the CES-D Scale (p=0.0001) and increased anxiety on the HADS (p=0. 0001 ..." | ||
| Vol 17, No 3 (2025) | Predicting clinical outcomes in patients with ischemic stroke following successful thrombectomy: clinical, neuroradiological, and periprocedural predictors | Abstract similar documents |
| K. V. Anisimov, N. Kh. Gorst, A. B. Berdalin, A. V. Kostin, K. N. Zhuravlev, D. V. Skrypnik, N. A. Shamalov | ||
| "... of the internal carotid artery (OR 0.25; 95% CI 0.06–0.97; p=0.045), hemorrhagic transformation (OR 0.10; 95% CI 0.03 ..." | ||
| Vol 10, No 1 (2018) | G308A tumor necrosis factor-α gene polymorphism and depression in an open male population aged 25–64 years from Novosibirsk (an epidemiological study according to the WHO MONICA-psychosocial program) | Abstract similar documents |
| I. V. Gagulin, E. A. Gromova, A. V. Gafarova, V. V. Gafarov | ||
| "... depression (8%) (χ2 =9.122; df=1; p=0.003; OR=2.296; 95% CI, 1.325–3.98). Discussion. Analysis ..." | ||
| Vol 17, No 1 (2025) | Emotional disturbances in patients in the remote postoperative period after surgical treatment of cerebral aneurysms | Abstract PDF (Eng) similar documents |
| I. M. Shetova I.M, T. A. Shatokhin, V. A. Luk'yanchikov, A. A. Yakovlev, M. A. Piradov, V. V. Krylov | ||
| "... with normal linear blood flow velocity compared to patients diagnosed with vasospasm (p=0.03). The condition ..." | ||
| 1 - 47 of 47 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
